Procainamide NEW
| Price | $33 |
| Package | 200mg |
| Supply Ability: | 10g |
| Update Time: | 2026-08-20 |
Product Details
| Product Name: Procainamide | CAS No.: 51-06-9 |
| Purity: 99.75% | Supply Ability: 10g |
| Release date: 2026/08/20 |
Product Introduction
Bioactivity
| Name | Procainamide |
| Description | Procainamide (Novocainamide) is a specific and potent DNA methyltransferase 1 (DNMT1) inhibitor and a Class 1A antiarrhythmic agent, with potential applications in cancer and arrhythmia research [1] [2]. |
| In vitro | HCT116, HCT116 DNMT1−/−, and HCT116 DNMT3b−/− cells were treated with PBS, pH 7.4 or 0.5 mM procainamide for 96 h. Procainamide treatment of HCT116 DNMT3b−/− cells decreased m5dC content by 11.5%, but treatment of HCT116 DNMT1−/− cells did not decrease m5dC content. These results suggested that DNMT1 was the intracellular target of procainamide[1]. |
| Storage | Keep away from direct sunlight Pure form: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature. |
| Solubility Information | DMSO : 250 mg/mL (1062.34 mM), Sonication is recommended. 10% DMSO+40% PEG300+5% Tween 80+45% Saline : 1 mg/mL (4.25 mM), Sonication is recommended. 10% DMSO+90% Saline : 10 mg/mL (42.49 mM), Solution. |
| Keywords | Procainamide | DNMT1 | DNAMethyltransferase | DNA Methyltransferase |
| Inhibitors Related | Carbamazepine | Uridine 5'-monophosphate disodium salt | Hydrochlorothiazide | 1,8-Cineole | Tetraethylammonium bromide | Tetraethylammonium chloride | Cesium chloride | Chenodeoxycholic acid | 4-Aminopyridine | 2,2,2-Trichloroethanol | Nifedipine | Indapamide |
| Related Compound Libraries | Failed Clinical Trials Compound Library | Approved Drug Library | Epigenetics Compound Library | Toxic Compound Library | Drug Repurposing Compound Library | Inhibitor Library | FDA-Approved Drug Library | Anti-Cancer Approved Drug Library | Bitter Compound library | Anti-Cancer Compound Library | Anti-Cancer Active Compound Library | Anti-Cancer Drug Library |
Company Profile Introduction
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
You may like
Recommended supplier
| Product name | Price | Suppliers | Update time | |
|---|---|---|---|---|
| $138.00 |
VIP3Y
|
TargetMol Chemicals Inc.
|
2026-08-08 | |
|
Hebei Yanxi Chemical Co., Ltd.
|
2025-06-20 | |||
| $10.00 |
Hebei Chuanghai Biotechnology Co., Ltd
|
2026-03-20 | ||
| $1.10 |
VIP6Y
|
Dideu Industries Group Limited
|
2026-08-20 | |
| $1.00 |
VIP7Y
|
Career Henan Chemical Co
|
2020-02-05 |
United States- Since: 2011-01-07
- Address: 36 Washington Street, Wellesley Hill, MA
INQUIRY